Theophylline-associated status epilepticus in an infant: pharmacokinetics and the risk of suppository use

[1]  T. Fuchigami,et al.  The relationship between drug treatment and the clinical characteristics of febrile seizures , 2008, World journal of pediatrics : WJP.

[2]  H. Yoshikawa.  First-line therapy for theophylline-associated seizures. , 2007, Acta neurologica Scandinavica.

[3]  N. Kondo,et al.  Intrinsic factors for unbound theophylline. , 2002, Journal of investigational allergology & clinical immunology.

[4]  N. Kondo,et al.  Developmental changes of unbound theophylline. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  N. Shimozawa,et al.  Theophylline-associated status epilepticus resulting in quadriplegia. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  N. Kondo,et al.  Prediction of steady-state serum theophylline concentration in children by first-order and zero-order absorption models. , 1994, International journal of clinical pharmacology and therapeutics.

[7]  D. Dunn,et al.  Theophylline and status epilepticus in children. , 1991, Neuropediatrics.

[8]  A. Nolke.  Severe toxic effects from aminophylline and theophylline suppositories in children. , 1956, Journal of the American Medical Association.